COMP <GO>
TMCI vs EMBC // EV/EBITDA & P/E VALUATION
Treace Medical Concepts Inc. (NASDAQ) VS. Embecta Corp. (NASDAQ) • 15-METRIC TALLY: TMCI 2
— EMBC 7
■ METRIC PARITY
LAST: $5.06 (+4.76%) • MKT CAP: $329.1M
valuation
—
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
valuation
6.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TMCI VS. EMBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TMCI | EMBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.80% | 62.60% | +17.20 | TMCI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.40% | 35.50% | -67.90 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 6.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.96% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -25.50% | 22.40% | -47.90 | EMBC | /operating-margins <GO> |
| Net Profit Margin | -27.70% | 8.80% | -36.50 | EMBC | /net-margins <GO> |
| Revenue Growth (YoY) | 1.60% | -3.80% | +5.40 | TMCI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 9.42% | -9.42 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.90 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | EMBC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.6 | 52.2 | -0.58 | EMBC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 3.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $329.1M | $371.7M | -$42.6M | EMBC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TMCI REV | EMBC REV | TMCI GROSS % | EMBC GROSS % | TMCI FCF | EMBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $212.7M | $1.08B | 79.8% | 62.6% | -$29.5M | $182.4M |
| FY 2024 | $209.4M | $1.12B | 80.4% | 65.5% | -$48.8M | $19.9M |
| FY 2023 | $187.1M | $1.12B | — | — | -$34.6M | $67.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TMCI // BETA —
EMBC // BETA —